Navigation Links
FDA Issues Complete Response Letter for Carisbamate
Date:8/21/2009

TITUSVILLE, N.J., Aug. 21 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) issued a complete response letter regarding the New Drug Application (NDA) for carisbamate, an anti-epileptic drug in development, announced Ortho-McNeil-Janssen Pharmaceuticals, Inc.

The NDA, filed in October 2008 by Johnson & Johnson Pharmaceutical Research and Development, L.L.C. (J&JPRD) on behalf of Ortho-McNeil-Janssen Pharmaceuticals, Inc. seeks approval to market carisbamate (COMFYDE(TM)) for the adjunctive treatment of partial onset seizures in patients 16 years of age and older.

The company is currently evaluating the FDA's complete response letter, and will respond to the agency's questions as quickly as possible.

About Partial Onset Seizures and Epilepsy

According to the Epilepsy Foundation, epilepsy is one of the most common disorders of the nervous system. It is defined by recurrent unprovoked seizures. It is categorized as "generalized" or "partial" depending on the location of the abnormal electrical activity in the brain that characterizes the disorder. Partial-onset seizures are common and are often difficult to treat. Partial-onset seizures are most often characterized by simple or complex repetitive movements, but virtually any sensory or emotional symptom can also occur as part of a partial seizure, including complex visual or auditory hallucinations. There are two categories of partial onset seizures: simple partial seizures (in which consciousness is retained), and complex partial seizures (in which consciousness is impaired or lost). Partial seizures can generalize and lead to tonic clonic seizures, during which the patient loses consciousness and is at risk for falling or injury.

About Carisbamate (COMFYDE (TM))

Carisbamate has demonstrated anti-epileptic drug activity when given in addition to other AEDs in clinical trials. A
'/>"/>

SOURCE Ortho-McNeil-Janssen Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. The First Annual Cervical Cancer/HPV Conference Tackles Controversial Vaccine Issues and Encourages Advocacy
2. European Unions CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
3. European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg)
4. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
5. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
6. QIAGEN and Center for Molecular Medicine Create Research Collaboration for Molecular Diagnostic Markers for Breast Cancer, Other Womens Health Issues
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Bioniche Life Sciences Inc.
8. Lupus Under the Spotlight: U.S. Congress Shows Support for Womens Health Issues
9. European Unions CHMP Issues Positive Opinion on Sugammadex
10. Newly Published Study Shows OPKOs siRNA Bevasiranib Is Taken Up by Target Tissues in the Eye
11. Ending Cervical Cancer Featured at Summit; QIAGEN CEO Issues a Call to Global Women Leaders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... a third of reproductive-aged women enrolled in Medicaid, and more ... prescription for an opioid pain medication each year during 2008-2012, ... Weekly Report (MMWR). Opioids are typically prescribed ... They are also found in some prescription cough medications. The ...
(Date:1/23/2015)... Jan. 23, 2015  HyGreen, Inc., a leader in hand ... with RCA Medical, a subsidiary of Ascendis Health Limited, ... Each year, hundreds of millions of patients around ... organisms are transmitted from patient to patient via the ...
(Date:1/23/2015)... LAS VEGAS , Jan. 23, 2015 Cord Blood ... CBAI ) ("CBAI" or the "Company")  filed a Preliminary Proxy ... ( www.sec.gov ) today, and provides an update for shareholders ... authorized shares is requested. Dear Shareholders, ...
Breaking Medicine Technology:Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3HyGreen Partners with RCA Medical in Johannesburg, South Africa 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4
... announces that a new market research report is available ... Markets and Companies http://www.reportlinker.com/p0203550/Proteomics---Technologies-Markets-and-Companies.html ... describes and evaluates the proteomic technologies that will play ... practice of medicine in the post-genomic era - the ...
... Spain, March 7, 2011 Grifols, a global healthcare ... announced that it has established an Expert Advisory Council ... renowned physicians and researchers from across the globe.  The ... insight, advice and guidance to Grifols, own transfusion medicine ...
Cached Medicine Technology:Reportlinker Adds Proteomics - Technologies, Markets and Companies 2Reportlinker Adds Proteomics - Technologies, Markets and Companies 3Grifols Establishes Expert Advisory Council in Transfusion Medicine 2Grifols Establishes Expert Advisory Council in Transfusion Medicine 3
(Date:1/22/2015)... Blue Cross and Blue Shield of Minnesota (Blue Cross) ... to “Live Fearless.” , The “Faces of Fearless” ... about how they or someone they know has faced a ... the moment. By telling these types of stories through livefearlessmn.com, ...
(Date:1/22/2015)... January 22, 2015 The federal court overseeing ... U.S. District Court, Southern District of West Virginia has upheld ... that proceeding’s first bellwether trial. In an Order dated January ... trial after finding that C.R. Bard had not proven a ...
(Date:1/22/2015)... Dallas, TX (PRWEB) January 22, 2015 ... the issue of experience and person-centeredness in the long-term ... moving towards action across the continuum. The paper, “The ... the Continuum,” engages perspectives and practices of the patient, ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Autocarinsurancebest.com has released ... purchasing a commercial auto insurance policy . , Auto ... their vehicles. It is no longer necessary to call an ... are now available online on a single website: http://autocarinsurancebest.com/ ...
(Date:1/22/2015)... January 22, 2015 Carinsurancesavings.biz has released a ... death and dismemberment insurance . , Purchasing an accidental ... be very advantageous. This type of rider provides benefits if ... can be considered a lesser form of life insurance. ...
Breaking Medicine News(10 mins):Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2
... The University HealthSystem Consortium (UHC) introduced the Tactics ... center to help its academic medical center members ... challenges of the current economic conditions have increased ... cost reduction initiatives and ideas. UHC,s Tactics ...
... had deficient levels, study shows , , WEDNESDAY, April 29 (HealthDay ... ill patients, new research shows. , In a small study, ... intensive care unit were deficient in vitamin D. , "Vitamin ... patients," said study author Dr. Paul Lee, an endocrinologist and ...
... ongoing debate regarding Hormone Replacement Therapy has been raging ... results of a controversial study released in 2002 have ... how to deal with unpleasant menopausal hormone symptoms caused ... and figures such as Oprah Winfrey, Suzanne Somers and ...
... GuidanceST. LOUIS, April 29 Express Scripts, Inc. (Nasdaq: ... operations of $214.7 million, or $0.86 per diluted share, which ... 2008. The Company reported first quarter cash flow from continuing ... year. "It has been a strong start to 2009 ...
... April 29 A drug widely used to treat ... legs syndrome (RLS) and helps people with the disorder get a ... as part of the Late-breaking Science Program at the American Academy ... 2, 2009. RLS affects up to one in ten people.The ...
... dangerous levels of artery-blocking proteins , , WEDNESDAY, April 29 ... artery disease has worked well in a small trial, ... of the protein collagen, which plays a major role ... von zur Muehlen, a fellow in cardiology at University ...
Cached Medicine News:Health News:University HealthSystem Consortium Launches Tactics for Tough Times Initiative to Help Members With Issues Such as Capacity and Medication Management 2Health News:Critically Ill Patients Lack Vitamin D 2Health News:Critically Ill Patients Lack Vitamin D 3Health News:Women's International Pharmacy Offers Free Educational Information About Bioidentical Hormone Replacement Therapy 2Health News:Women's International Pharmacy Offers Free Educational Information About Bioidentical Hormone Replacement Therapy 3Health News:Express Scripts Reports First Quarter EPS of $0.86, up 23% 2Health News:Express Scripts Reports First Quarter EPS of $0.86, up 23% 3Health News:Express Scripts Reports First Quarter EPS of $0.86, up 23% 4Health News:Express Scripts Reports First Quarter EPS of $0.86, up 23% 5Health News:Express Scripts Reports First Quarter EPS of $0.86, up 23% 6Health News:Express Scripts Reports First Quarter EPS of $0.86, up 23% 7Health News:Express Scripts Reports First Quarter EPS of $0.86, up 23% 8Health News:Express Scripts Reports First Quarter EPS of $0.86, up 23% 9Health News:Express Scripts Reports First Quarter EPS of $0.86, up 23% 10Health News:Express Scripts Reports First Quarter EPS of $0.86, up 23% 11Health News:New Treatment Discovered for Restless Legs Syndrome Improves Sleep 2Health News:Urine Test for Heart Disease Shows Promise 2
... Available in even sizes 20-36F. A ... patient comfort., ,The Latex-Free Robertazzi ... patient comfort while offering the best ... economically priced allowing you to offer ...
Silkolatex™ . Adjustable flange. Single use....
All oral and nasal airways are manufactured with smooth, rounded edges for increased patient comfort and safety., ,Portex® offers a broad selection of airways for a variety of clinical applicati...
Guedel-style enclosed center channel. Semirigid, nontoxic polyethylene with color-coded bite block. Individually packaged, 48 per case. Latex Free....
Medicine Products: